Marjolein Brekelmans

1.4k total citations · 1 hit paper
19 papers, 628 citations indexed

About

Marjolein Brekelmans is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Marjolein Brekelmans has authored 19 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Internal Medicine, 15 papers in Cardiology and Cardiovascular Medicine and 5 papers in Hematology. Recurrent topics in Marjolein Brekelmans's work include Venous Thromboembolism Diagnosis and Management (17 papers), Atrial Fibrillation Management and Outcomes (15 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Marjolein Brekelmans is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (17 papers), Atrial Fibrillation Management and Outcomes (15 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Marjolein Brekelmans collaborates with scholars based in Netherlands, United States and United Kingdom. Marjolein Brekelmans's co-authors include Harry R. Büller, Saskia Middeldorp, Walter Ageno, Barbara A. Hutten, Rupert Bauersachs, Charalambos Vlachopoulos, Adriano Alatri, Adam Torbicki, Victor Aboyans and Lucia Mazzolai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Marjolein Brekelmans

19 papers receiving 612 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function

2017 252 citations Lucia Mazzolai, Victor Aboyans et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marjolein Brekelmans Netherlands	14	476	368	165	108	83	19	628
Beat Frauchiger Switzerland	19	475 1.0×	530 1.4×	186 1.1×	72 0.7×	92 1.1×	50	873
B. Tardy-Poncet France	15	351 0.7×	226 0.6×	282 1.7×	187 1.7×	31 0.4×	31	627
Ghazi Alotaibi Saudi Arabia	12	408 0.9×	290 0.8×	136 0.8×	131 1.2×	67 0.8×	30	582
Ricardo Guijarro Spain	14	571 1.2×	447 1.2×	135 0.8×	53 0.5×	84 1.0×	23	842
Kerstin Hogg United Kingdom	13	382 0.8×	283 0.8×	166 1.0×	61 0.6×	65 0.8×	41	588
Volkmar Lufft Germany	13	248 0.5×	353 1.0×	148 0.9×	44 0.4×	24 0.3×	18	813
Anne‐Céline Martin France	15	396 0.8×	525 1.4×	149 0.9×	81 0.8×	40 0.5×	51	774
Carlo Bova Italy	12	696 1.5×	461 1.3×	215 1.3×	72 0.7×	100 1.2×	32	861
Yevgeniy Brailovsky United States	10	210 0.4×	168 0.5×	74 0.4×	22 0.2×	42 0.5×	81	445
R. Hull Canada	8	822 1.7×	605 1.6×	359 2.2×	225 2.1×	121 1.5×	15	1.0k

Countries citing papers authored by Marjolein Brekelmans

Since Specialization

Citations

This map shows the geographic impact of Marjolein Brekelmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjolein Brekelmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjolein Brekelmans more than expected).

Fields of papers citing papers by Marjolein Brekelmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjolein Brekelmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjolein Brekelmans. The network helps show where Marjolein Brekelmans may publish in the future.

Co-authorship network of co-authors of Marjolein Brekelmans

This figure shows the co-authorship network connecting the top 25 collaborators of Marjolein Brekelmans. A scholar is included among the top collaborators of Marjolein Brekelmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjolein Brekelmans. Marjolein Brekelmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Brinkman, Herm Jan M., Marjolein Brekelmans, Eva N. Hamulyák, et al.. (2020). Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate. Research and Practice in Thrombosis and Haemostasis. 4(4). 569–581. 19 indexed citations

Kraaijpoel, Noémie, Nick van Es, Suzanne M. Bleker, et al.. (2018). Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients. Thrombosis and Haemostasis. 118(1). 174–181. 6 indexed citations

Brekelmans, Marjolein, Harry R. Büller, Michele Mercuri, et al.. (2018). Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent. SHILAP Revista de lepidopterología. 2(1). e1–e7. 3 indexed citations

Brekelmans, Marjolein, Manon Kappelhof, Pythia T. Nieuwkerk, et al.. (2017). Preference for direct oral anticoagulants in patients treated with vitamin K antagonists for venous thromboembolism.. PubMed. 75(2). 50–55. 13 indexed citations

Eerenberg, Elise S., et al.. (2017). Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. Thrombosis and Haemostasis. 117(10). 1944–1951. 26 indexed citations

Bleker, Suzanne M., Barbara A. Hutten, Anne Timmermans, et al.. (2017). Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin. Thrombosis and Haemostasis. 117(4). 809–815. 54 indexed citations

Brekelmans, Marjolein, Luuk J.J. Scheres, Barbara A. Hutten, et al.. (2017). Clinical outcome of patients with a vitamin K antagonist‐associated bleeding treated with prothrombin complex concentrate. Research and Practice in Thrombosis and Haemostasis. 2(1). 77–84. 6 indexed citations

Brekelmans, Marjolein, et al.. (2017). Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis. Journal of Thrombosis and Thrombolysis. 44(1). 118–129. 40 indexed citations

Scheres, Luuk J.J., Marjolein Brekelmans, Ludo F.M. Beenen, et al.. (2017). Sex‐specific differences in the presenting location of a first venous thromboembolism. Journal of Thrombosis and Haemostasis. 15(7). 1344–1350. 23 indexed citations

10.

Raskob, Gary E., Walter Ageno, Alexander T. Cohen, et al.. (2017). Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study. Thrombosis and Haemostasis. 117(12). 2406–2414. 7 indexed citations

11.

Vanassche, Thomas, Peter Verhamme, Philip S. Wells, et al.. (2017). Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial. Thrombosis Research. 162. 7–14. 22 indexed citations

12.

Mazzolai, Lucia, Victor Aboyans, Walter Ageno, et al.. (2017). Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. European Heart Journal. 39(47). 4208–4218. 252 indexed citations breakdown →

13.

Brekelmans, Marjolein, Walter Ageno, Ludo F.M. Beenen, et al.. (2016). Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study. The Lancet Haematology. 3(9). e437–e445. 25 indexed citations

14.

Barco, Stefano, et al.. (2016). Home parenteral nutrition‐associated thromboembolic and bleeding events: results of a cohort study of 236 individuals. Journal of Thrombosis and Haemostasis. 14(7). 1364–1373. 15 indexed citations

15.

Wells, Philip, Annelise Segers, Walter Ageno, et al.. (2016). Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. Thrombosis and Haemostasis. 116(10). 747–753. 30 indexed citations

16.

Brekelmans, Marjolein, Niki Fens, Paul Brinkman, et al.. (2016). Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference Study. PLoS ONE. 11(3). e0151715–e0151715. 25 indexed citations

17.

Brekelmans, Marjolein, Rupert Bauersachs, Z Boda, et al.. (2016). Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists. Thrombosis and Haemostasis. 116(7). 155–161. 15 indexed citations

18.

Raskob, Gary E., Walter Ageno, Alexander T. Cohen, et al.. (2016). Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study. The Lancet Haematology. 3(5). e228–e236. 46 indexed citations

19.

Kraaijpoel, Noémie, Nick van Es, Suzanne M. Bleker, et al.. (2016). Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients. Blood. 128(22). 2611–2611. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact